Disclosures for "‘Un-picking the Bone-health Management' in Adult Spinal Muscular Atrophy (SMA) Patients: Multi-centre UK Audit "
-
Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARENX. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Hewamadduma has received research support from Neurocare . The institution of Dr. Hewamadduma has received research support from Sheffield Charitable Trust. Dr. Hewamadduma has received personal compensation in the range of $5,000-$9,999 for serving as a Adult Expert with National Health Service England (NHSE).
-
Dr. Chapman has nothing to disclose.
-
Miss McNicholas has nothing to disclose.
-
Dr. Cousins has nothing to disclose.
-
Dr. Borg has nothing to disclose.
-
Dr. Navalgaria has nothing to disclose.
-
Mrs. Maidment has nothing to disclose.
-
Dr. Cader has nothing to disclose.
-
Dr. Tanzi has nothing to disclose.
-
Ms. Rutherford has nothing to disclose.
-
Mrs. Chatfield has received research support from Roche .
-
Mr. Kelly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Kelly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Kelly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurology Academy.
-
The institution of Mr. Street has received research support from Sheffield Hospitals Charity.
-
Mrs. Nevin has received personal compensation for serving as an employee of Biogen . Mrs. Nevin has received personal compensation for serving as an employee of Roche .
-
Dr. Galtrey has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Galtrey has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. The institution of Dr. Galtrey has received research support from Roche.
-
Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.